Related resources
Search for item elsewhere
University researcher(s)
Academic department(s)
Ca(2+) sparks and BK currents in gallbladder myocytes: role in CCK-induced response.
Pozo M, PĂ©rez G, Nelson MT, Mawe G
American Journal of Physiology-Gastrointestinal and Liver Physiology. 2002;282( 1):G165-74.
Access to files
Full-text and supplementary files are not available from Manchester eScholar. Use our list of Related resources to find this item elsewhere. Alternatively, request a copy from the Library's Document supply service.
Abstract
We sought to elucidate the regulation of gallbladder smooth muscle (GBSM) excitability by localized Ca(2+) release events (sparks) and large-conductance Ca(2+)-dependent (BK) channels by determining whether sparks exist in GBSM and, if so, whether they activate BK channels. Sparks were identified in isolated GBSM loaded with fluo 4. Each spark was associated with a transient outward current, suggesting communication of ryanodine receptor (RyR) channels with BK channels. This was confirmed by the inhibition of outward currents with iberiotoxin (100 nM), thapsigargin (200 nM), and ryanodine (10 microM). In current clamp mode, the transient BK currents were associated with brief membrane hyperpolarizations (10.9 +/- 1.3 mV). Because transient BK currents could dampen GBSM excitability, we tested whether CCK attenuates these events. CCK (10 nM) reduced the amplitude and frequency of transient BK currents, and subsequent caffeine application restored transient BK current activity. These results support the concept that RyRs and BK channels contribute to the regulation of GBSM excitability and that CCK can act in part by inhibiting this pathway.
Keyword(s)
Aniline Compounds; Animals; Fluorescent Dyes; Guinea Pigs; Large-Conductance Calcium-Activated Potassium Channels; Patch-Clamp Techniques; Potassium Channels, Calcium-Activated; Xanthenes; cytology: Gallbladder; cytology: Muscle, Smooth; drug effects: Calcium Signaling; drug effects: Membrane Potentials; metabolism: Calcium; metabolism: Calcium Channels, L-Type; metabolism: Potassium; metabolism: Potassium Channels; metabolism: Ryanodine Receptor Calcium Release Channel; metabolism: Sarcoplasmic Reticulum; pharmacology: Boron Compounds; pharmacology: Caffeine; pharmacology: Calcium Channel Blockers; pharmacology: Cholecystokinin; pharmacology: Enzyme Inhibitors; pharmacology: Nifedipine; pharmacology: Peptides; pharmacology: Phosphodiesterase Inhibitors; pharmacology: Ryanodine; pharmacology: Thapsigargin